Details for New Drug Application (NDA): 021107

✉ Email this page to a colleague

NDA 021107 describes LOTRONEX, which is a drug marketed by Sebela Ireland Ltd and is included in one NDA. It is available from two suppliers. Additional details are available on the LOTRONEX profile page.

The generic ingredient in LOTRONEX is alosetron hydrochloride. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the alosetron hydrochloride profile page.

Summary for 021107

Tradename:	LOTRONEX
Applicant:	Sebela Ireland Ltd
Ingredient:	alosetron hydrochloride
Patents:	0

Pharmacology for NDA: 021107

Mechanism of Action	Serotonin 3 Receptor Antagonists

Suppliers and Packaging for NDA: 021107

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LOTRONEX	alosetron hydrochloride	TABLET;ORAL	021107	NDA AUTHORIZED GENERIC	Actavis Pharma, Inc.	45963-479	45963-479-03	1 BOTTLE in 1 CARTON (45963-479-03) / 30 TABLET in 1 BOTTLE
LOTRONEX	alosetron hydrochloride	TABLET;ORAL	021107	NDA AUTHORIZED GENERIC	Actavis Pharma, Inc.	45963-480	45963-480-03	1 BOTTLE in 1 CARTON (45963-480-03) / 30 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 1MG BASE
Approval Date:	Feb 9, 2000	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 0.5MG BASE
Approval Date:	Dec 23, 2003	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021107

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sebela Ireland Ltd	LOTRONEX	alosetron hydrochloride	TABLET;ORAL	021107-002	Dec 23, 2003	⤷ Subscribe	⤷ Subscribe
Sebela Ireland Ltd	LOTRONEX	alosetron hydrochloride	TABLET;ORAL	021107-001	Feb 9, 2000	⤷ Subscribe	⤷ Subscribe
Sebela Ireland Ltd	LOTRONEX	alosetron hydrochloride	TABLET;ORAL	021107-001	Feb 9, 2000	⤷ Subscribe	⤷ Subscribe
Sebela Ireland Ltd	LOTRONEX	alosetron hydrochloride	TABLET;ORAL	021107-002	Dec 23, 2003	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.